<!--START from /var/www/html/php4/ydp_trunk/local/templates/ydpprotocol/protocol_form_template.html comment made with MMCM-->
{clni_form}
<h3>Hypertension</h3>
1. Key elements of the history/physical that are treatment targets for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="history_targets" type="text" size="50"
value="Years of known hypertension, complications (CAD, ESRD, Opthal, Stroke), treatment history, smoking history, obesity. Fundoscopic exam, cardiovascular, peripheral edema, blood pressure, Body Mass Index (BMI).

"}<br>

2. What are the patients Risk Factors that are treatment targets for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="risk_factors" type="text" size="50" 
value="Family history, obesity, protocol not indicated or contraindicated, patient declined, economic, social, religious, resource unavailable, insurance limitations, other
"}<br>

3. What are the Treatment Goals for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="treatment_goals" type="text" size="50" 
value="Decreased blood pressure or blood pressure in normal range.
"}<br>

4. What are the typical Medications for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="medications" type="text" size="50" 
value="Thiazide diuretics: chlorothiazide, chlorthalidone, hydrochlorothiazide, polyuthiazide, indapamide, matolazone
Loop diurectics: bumetanide, furosemide, torsemide
Potassium-sparing diuretics: amiloride, triamterene
Aldosterone receptor blockers: eplereonone, spironolactone
Beta Blockers (BB): atenolol, betazaolol, bisoprolol, meoprolol, metoprolol, extended release, nadolol, propranolol, timolol
Beta Blockers with sympathomimetic activity: acebutolol, penbutolol, pindolol
Combined alpha and BB: carvedilol, labetalol
Angiotensin Converting Enzyme Inhibitors (ACEIs): benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindo;rio, quinapril, ramipril, trandolapril
Angiotensin II antagonists: candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan
Calcium Channel Blockers (CCB)- non-dihydropyridines: diltiazem, verapamil
CCBs-Dyhdropyridines: amolodipine, felodipine, isradipine, nicardipine, nifedipine, nisoldipine
Alpha-1 Blockers: doxazosin, prazosin, terazosin
Central alpha-2 agonists: clonidine, methyldopa, reserpine, guanfacine
Direct Vasodilators: hydralazine, minoxidil
ACEIs/ CCBs: amlodipine-benezepril hydrochloride, enalapril-felodipine, trandolarpril-verapamil
ACEIs and diurectics: Benazepril-hydrochorathiazide, captopril-hydrochlorothiazide, Enalapril-hydrocholorthiazide, fosinopril-hydrochlorothiazide, lisinopril-hydrochlorothiazide, moexipril-hydrochlorthiazide, quinapril-hydrochlorothiazide
ARBs and diurectics: Candesartan-hydrochlorothiazide, eprosartan-hydrochlorothiazide, irbesartan-hydrochlorothiazide, losartan-hydrochlorothiazide, olmesartan medoxomil-hydrochlorothiazide, telmisartan-hydrochlorothiazide, valsartan-hydrochlorothiazide
BBs and diurectics: atenolol-chlorthalidone, bisoprolol-hydrochlorothiazide, olmesartan medoxomil-hydrochlorothiazide, telmisartan-hydrochlorothiazide, valsartan-hydrochlorathiazide
Central/ diuretic: methyldopa-hydrochlorothiazide, reserpine-chlorthalidone, reserpine-chlorothiazide, reserpine-hydrochlorothiazide
Diuretic-diuretic: amiloride-hydrochlorothiazide, sprionolactone-hydrochlorothiazide, triamterene-hydrochlorthiazide

"}<br>

5. Indications for lab studies for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="lab_studies" type="text" size="50" 
value="Serum Electrolytes, Glucose, Renal Function, Urinalysis, Lipids.
"}<br>

6. Indications for imaging studies for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="imaging_studies" type="text" size="50" 
value="Baseline EKG
"}<br>

7. Outcome goals for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="followup" type="text" size="50"
value="Key indicators
Percentage of patients with blood pressure recorded
Percentage of patients with most recent recorded BP < 140/90
Patients with BP >140/90 with documented plan of care
YDP additional standards
Patient understanding of disease, satisfaction with care
Percentage goals met per risk factor adjusted diagnosis
Percentage of patients weight weighed and counselled on weight, exercise

"}<br>

8. Referral criteria, if referring patient out for Hypertension?<br>
{input style="width: 6in; height: 1in;" name="followup" type="text" size="50"
value="Retinopathy: Abnormal exam or unable to visualize
Nephrology: Creatinine above 2.0, Microabluminuria persists with good blood pressure control
Nutrition: New onset diabetes, BMI > 25
Hypertension: Maximize treatment and not to goal

"}<br>

<input type='hidden' name='force_new_version' value='true'>

<input type='hidden' name="external_id" value="{$user_id}" id="external_id">
{submit}
</form>
<!--END from /var/www/html/php4/ydp_trunk/local/templates/ydpprotocol/protocol_form_template.html comment made with MMCM-->